Search

everythinglearnresearchcommunity

for

Search:↓

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

STK11 gene polymorphism does not predict metformin response in PCOS.

Most non-medical students at Tarumanagara University have good knowledge and attitudes about PCOS.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

Acupressure improves quality of life in PCOS patients.

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

A woman's diabetes improved after removing ovarian tumors that caused high testosterone levels.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

The painting of an 18th-century Sicilian baroness shows she had hair loss, possibly due to ovarian issues, insulin resistance, or a specific type of tumor.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

A rare ovarian tumor was diagnosed in a woman from North Brazil, and surgery is the preferred treatment.